The WFH Humanitarian Aid Program made it possible for a man to survive a serious accident in Hyderabad, Pakistan. Sarfaraz—a 22 year old man with hemophilia A—was involved in a car accident on the highway and was badly wounded. Thanks to WFH Humanitarian Aid Program donations, he was able to get the factor he needed to make a full recovery.
Sarfaraz’s accident happened on April 23, 2020. He was immediately brought to the Civil Hospital in Hyderabad and then transferred to National Institute of Blood Disease & Bone Marrow Transplantation (NIBD) hospital, 150 kilometers away in Karachi, Pakistan. There, he was placed under the care of Munira Borhany, MD. Thanks to the efforts of the Hemophilia Welfare Society Karachi (HWSK) and the Hemophilia Foundation of Pakistan (HFP), he received critically-needed donated product provided by the WFH Humanitarian Aid Program.
The donated factor saved Sarfaraz’s life. He suffered massive bleeds covering his whole head, face and eyes. He also had multiple bruises and lacerations on his body. Fortunately, CT scans showed neither intracranial bleeding nor any fractures. From his time in the emergency room to his discharge, he received donated factor a number of times. He continued receiving factor after his discharge, and is currently under the care of the HWSK Hemophilia Treatment Centre (HTC).
Thanks to the WFH Humanitarian Aid Program, Pakistan has received over 38 million IUs of Clotting Factor Concentrates (CFCs) since 2015, with over 8 million IUs of CFCs sent in 2019 alone. These donations have allowed hundreds of people—including children—to enjoy a better quality of life.
About the WFH Humanitarian Aid Program
The expanded WFH Humanitarian Aid Program improves the lack of access to care and treatment by providing much needed support for people with inherited bleeding disorders in developing countries. By providing patients with a more predictable and sustainable flow of humanitarian aid donations, the WFH Humanitarian Aid Program makes it possible for patients to receive consistent and reliable access to treatment and care. None of this would be possible without the generous support of Sanofi Genzyme and Sobi, our Visionary Contributors; Grifols, CSL Behring, GC Pharma, our Corporate partners; and Roche and Bayer, our newest donors. To learn more about the WFH Humanitarian Aid Program, visit www.treatmentforall.org.